Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
9 May 2016 |
Main ID: |
NCT01929668 |
Date of registration:
|
23/08/2013 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Inactive UC Patients
2SCANI |
Scientific title:
|
Comparison of 4L Polyethylene Glycol and 2L Polyethylene Glycol With Ascorbic Acid in Patients With Inactive Ulcerative Colitis; Randomized, Single Blind, Multicenter Study |
Date of first enrolment:
|
August 2013 |
Target sample size:
|
114 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT01929668 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Screening
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Korea, Republic of
| | | | | | | |
Contacts
|
Name:
|
Eun Soo Kim, MD, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Keimyung University School of Medicine |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- age >18 years old
- ulcerative colitis patients without symptoms for at least 1 year
- ulcerative colitis patients who undergo colonoscopy for surveillance
Exclusion Criteria:
- subjects who had abdominal surgery
- pregnant or breast feeding
Age minimum:
18 Years
Age maximum:
80 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Ulcerative Colitis
|
Intervention(s)
|
Drug: Ascorbic Acid
|
Drug: polyethylene glycol
|
Primary Outcome(s)
|
Number of patients who are willing to use the same preparation method for the next colonoscopy.
[Time Frame: day 1]
|
Secondary Outcome(s)
|
Number of patients who have ulcerative colitis symptom aggravation within 30 days after bowel preparation, measured by simple clinical colitis activity index (SCCAI).
[Time Frame: within 30 days after bowel preparation for colonoscopy]
|
Secondary ID(s)
|
2013-07-036-002
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|